ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2018)Next qtr. (Jun 2018)Current year (2018)Next year (2019)
No. of analysts0344
Avg. Estimate0-0.31-1.07-0.88
Low estimate0-0.36-1.58-1.81
High estimate0-0.29-0.27-0.29
Year ago EPSN/AN/AN/A-1.07
Revenue estimateCurrent qtr. (Mar 2018)Next qtr. (Jun 2018)Current year (2018)Next year (2019)
No. of analysts2455
Avg. EstimateN/AN/AN/A9.99M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A46M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Mar 2018)Next qtr. (Jun 2018)Current year (2018)Next year (2019)
Current estimate0-0.31-1.07-0.88
7 days ago-0.24-0.31-1.07-0.87
30 days ago-0.24-0.31-1.34-1.05
60 days ago0000
90 days ago0000
EPS revisionsCurrent qtr. (Mar 2018)Next qtr. (Jun 2018)Current year (2018)Next year (2019)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesASLNIndustrySectorS&P 500
Current qtr.N/AN/AN/A0.43
Next qtr.N/AN/AN/A0.47
Current yearN/AN/AN/A0.22
Next year17.80%N/AN/A0.10
Next 5 years (per annum)N/AN/AN/A0.11
Past 5 years (per annum)N/AN/AN/AN/A